Biotech Bay
Filter News
Found 56,424 articles
-
Inheris Biopharma was formed as Nektar awaits the FDA approval of a pain medication that does not have the euphoric side effects of other opioids.
-
Dynavax plans to step away from immuno-oncology development and will lay off 37% of its staff as a result.
-
BioSpace Movers and Shakers, May 24
5/24/2019
Biopharma companies from across the globe strengthen their leadership teams with key executive appointments. -
Aimmune to Present AR101 Data at European Academy of Allergy and Clinical Immunology 2019 Congress
5/24/2019
Full Results from Phase 3 ARTEMIS Study Will Be Featured
-
FLX Bio Announces Name Change to RAPT Therapeutics
5/24/2019
Name Reflects Our Focus on Defeating Cancer and Allergic Inflammatory Diseases
-
Amprion Joins the Fight Against Parkinson's Through Early Detection Testing
5/23/2019
Amprion today announced its proprietary technology, Protein Misfolding Cyclic Amplification (PMCA) using CSF and plasma alpha-Synuclein (αS) to aid in the diagnosis of Parkinson's disease, received a Breakthrough Device designation from U.S. FDA.
-
Bio-Rad to Participate at Jefferies 2019 Global Healthcare Conference on June 4
5/23/2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, and Ilan Daskal, Executive Vice President and CFO, will participate in Jefferies 2019 Global Healthcare Conference on Tuesday, June 4, at 10 AM (Eastern Time), in New York, NY.
-
Prominent Technologist William F. (Bill) Stasior Joins Avellino Labs Executive Advisory Committee
5/23/2019
Stasior to Lead Build-Out of Data Infrastructure for the Genetic Diagnostic and Therapeutic Technology Company
-
Modern Health Raises a $9M Series A Round Led by Kleiner Perkins
5/23/2019
Mamoon Hamid Joins Board of Directors
-
Roche receives FDA clearance to expand testing menu on cobas 6800/8800 Systems for sexually transmitted diseases
5/23/2019
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) 510(k) clearance for the cobas® TV/MG test for use on the cobas® 6800/8800 Systems for the detection of Trichomonas vaginalis (TV) and/or Mycoplasma genitalium
-
Veracyte Announces New Data Demonstrating Afirma Xpression Atlas’s Potential to Inform Treatment Selection for Patients with Medullary Thyroid Cancer to Be Presented at 2019 ASCO Annual Meeting
5/23/2019
American Society of Clinical Oncology (ASCO) Annual Meeting being held May 31-June 4, 2019 in Chicago.
-
Precision Wellness Pioneers Integrative Approach to Precision Health and Personalized Nutrition for Managing Cardiometabolic Health
5/23/2019
Precision Wellness, a Silicon Valley-based company at the intersection of next-generation AI, big data analytics and the latest medical science, today announced plans to harness the power of multiomics to deliver personalized health insights and a customized nutrition plan for disease prevention and healthy aging.
-
HBI Solutions Joins Iatric® Systems, Inc AI Solutions Center
5/23/2019
Bringing advanced analytics and artificial intelligence to care givers to address risk in real time
-
Twist Bioscience Strengthens Board With Semiconductor and Storage Expert Nelson C. Chan
5/23/2019
Replaces Paul Conley on Board of Directors
-
Ancestry to Boost Performance and Efficiency of Cloud Applications with Opsani's Continuous Optimization AI
5/23/2019
Opsani, the leading provider of AI-driven continuous optimization for cloud applications, has entered into an agreement with Ancestry®, the global leader in family history and consumer genetics services
-
Nektar Announces the Launch of Inheris Biopharma, Inc.
5/23/2019
Nektar Therapeutics announced the formation of Inheris Biopharma, Inc., a wholly-owned subsidiary of Nektar and a CNS-focused company.
-
Cardinal Analytx Closes $22 Million Series B Round
5/23/2019
Round by John Doerr, GuideWell, Blue Shield California and Premera Blue Cross Will Support Accelerated Hiring and Continued Innovation to Meet Fast-Growing Customer Demand
-
Univfy to Present at Deep Learning in Healthcare Summit and BIO 2019
5/23/2019
Univfy, an AI and machine learning company with a mission to expand in-vitro fertilization access and affordability, will be presenting at the upcoming conferences
-
Elixir Medical Announces Outstanding 9 and 12-Month Clinical and Imaging Results for the Transformational DynamX™ Bioadaptor at EuroPCR
5/23/2019
Long-term data demonstrate that the DynamX Bioadaptor implant and vessel growth accommodates neo-intimal hyperplasia to substantially maintain vessel lumen area in the treatment of coronary artery disease
-
Anatomage Kicks Off An Academic Sports Event Designed for High School Students
5/23/2019
Anatomage Inc, a market leader in 3D medical virtualization technology, hosted its second annual Anatomy Tournament - which was co-sponsored by AACI - at California State University, Northridge.